ID   USH1G_HUMAN             Reviewed;         461 AA.
AC   Q495M9; Q8N251;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   28-JUN-2023, entry version 162.
DE   RecName: Full=pre-mRNA splicing regulator USH1G {ECO:0000305};
DE   AltName: Full=Scaffold protein containing ankyrin repeats and SAM domain;
DE   AltName: Full=Usher syndrome type-1G protein;
GN   Name=USH1G; Synonyms=SANS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH PDZD7.
RX   PubMed=19028668; DOI=10.1093/hmg/ddn395;
RA   Schneider E., Marker T., Daser A., Frey-Mahn G., Beyer V., Farcas R.,
RA   Schneider-Ratzke B., Kohlschmidt N., Grossmann B., Bauss K., Napiontek U.,
RA   Keilmann A., Bartsch O., Zechner U., Wolfrum U., Haaf T.;
RT   "Homozygous disruption of PDZD7 by reciprocal translocation in a
RT   consanguineous family: a new member of the Usher syndrome protein
RT   interactome causing congenital hearing impairment.";
RL   Hum. Mol. Genet. 18:655-666(2009).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH MYO7A;
RP   USH1C AND USH1G.
RX   PubMed=21709241; DOI=10.1073/pnas.1104161108;
RA   Grati M., Kachar B.;
RT   "Myosin VIIa and sans localization at stereocilia upper tip-link density
RT   implicates these Usher syndrome proteins in mechanotransduction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:11476-11481(2011).
RN   [5]
RP   FUNCTION, INTERACTION WITH MAGI2, PHOSPHORYLATION AT SER-422, AND
RP   MUTAGENESIS OF SER-422.
RX   PubMed=24608321; DOI=10.1093/hmg/ddu104;
RA   Bauss K., Knapp B., Jores P., Roepman R., Kremer H., Wijk E.V., Maerker T.,
RA   Wolfrum U.;
RT   "Phosphorylation of the Usher syndrome 1G protein SANS controls Magi2-
RT   mediated endocytosis.";
RL   Hum. Mol. Genet. 23:3923-3942(2014).
RN   [6]
RP   INTERACTION WITH IFT20; IFT52 AND IFT57, AND CHARACTERIZATION OF VARIANT
RP   USH1G PRO-48 AND VARIANT VAL-104.
RX   PubMed=31637240; DOI=10.3389/fcell.2019.00216;
RA   Sorusch N., Yildirim A., Knapp B., Janson J., Fleck W., Scharf C.,
RA   Wolfrum U.;
RT   "SANS (USH1G) Molecularly Links the Human Usher Syndrome Protein Network to
RT   the Intraflagellar Transport Module by Direct Binding to IFT-B Proteins.";
RL   Front. Cell Dev. Biol. 7:216-216(2019).
RN   [7]
RP   FUNCTION, INTERACTION WITH SF3B1; PRPF6; PRPF31; SON AND U4/U6.U5 TRI-SNRNP
RP   COMPLEX, SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANT VAL-104.
RX   PubMed=34023904; DOI=10.1093/nar/gkab386;
RA   Yildirim A., Mozaffari-Jovin S., Wallisch A.K., Schaefer J., Ludwig S.E.J.,
RA   Urlaub H., Luehrmann R., Wolfrum U.;
RT   "SANS (USH1G) regulates pre-mRNA splicing by mediating the intra-nuclear
RT   transfer of tri-snRNP complexes.";
RL   Nucleic Acids Res. 49:5845-5866(2021).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 388-461 IN COMPLEX WITH USH1C,
RP   INTERACTION WITH USH1C, SUBCELLULAR LOCATION, AND CHARACTERIZATION OF
RP   VARIANT USH1G VAL-458.
RX   PubMed=20142502; DOI=10.1073/pnas.0911385107;
RA   Yan J., Pan L., Chen X., Wu L., Zhang M.;
RT   "The structure of the harmonin/sans complex reveals an unexpected
RT   interaction mode of the two Usher syndrome proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:4040-4045(2010).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 295-390 IN COMPLEX WITH MYO7A,
RP   STRUCTURE BY NMR OF 370-380, INTERACTION WITH MYO7A, AND MUTAGENESIS OF
RP   PHE-307; PHE-317 AND TRP-374.
RX   PubMed=21311020; DOI=10.1126/science.1198848;
RA   Wu L., Pan L., Wei Z., Zhang M.;
RT   "Structure of MyTH4-FERM domains in myosin VIIa tail bound to cargo.";
RL   Science 331:757-760(2011).
RN   [10]
RP   VARIANT USH1G PRO-48, INTERACTION WITH USH1C, TISSUE SPECIFICITY, AND
RP   POSSIBLE FUNCTION.
RX   PubMed=12588794; DOI=10.1093/hmg/ddg051;
RA   Weil D., El-Amraoui A., Masmoudi S., Mustapha M., Kikkawa Y., Laine S.,
RA   Delmaghani S., Adato A., Nadifi S., Zina Z.B., Hamel C., Gal A., Ayadi H.,
RA   Yonekawa H., Petit C.;
RT   "Usher syndrome type I G (USH1G) is caused by mutations in the gene
RT   encoding SANS, a protein that associates with the USH1C protein,
RT   harmonin.";
RL   Hum. Mol. Genet. 12:463-471(2003).
RN   [11]
RP   VARIANT USH1G VAL-458.
RX   PubMed=16283141; DOI=10.1007/s00109-005-0719-4;
RA   Kalay E., de Brouwer A.P.M., Caylan R., Nabuurs S.B., Wollnik B.,
RA   Karaguzel A., Heister J.G.A.M., Erdol H., Cremers F.P.M., Cremers C.W.R.J.,
RA   Brunner H.G., Kremer H.;
RT   "A novel D458V mutation in the SANS PDZ binding motif causes atypical Usher
RT   syndrome.";
RL   J. Mol. Med. 83:1025-1032(2005).
RN   [12]
RP   INVOLVEMENT IN NON-SYNDROMIC SENSORINEURAL HEARING LOSS, AND VARIANT
RP   VAL-104.
RX   PubMed=25255398; DOI=10.1097/aud.0000000000000095;
RA   Oonk A.M., van Huet R.A., Leijendeckers J.M., Oostrik J., Venselaar H.,
RA   van Wijk E., Beynon A., Kunst H.P., Hoyng C.B., Kremer H., Schraders M.,
RA   Pennings R.J.;
RT   "Nonsyndromic hearing loss caused by USH1G mutations: widening the USH1G
RT   disease spectrum.";
RL   Ear Hear. 36:205-211(2015).
CC   -!- FUNCTION: Plays a role in pre-mRNA splicing by regulating the release
CC       and transfer of U4/U6.U5 tri-small nuclear ribonucleoprotein (tri-
CC       snRNP) complexes from their assembly site in Cajal bodies to nuclear
CC       speckles, thereby contributing to the assembly of the pre-catalytic
CC       spliceosome on target pre-mRNAs (PubMed:34023904). May also participate
CC       in recycling of snRNPs back to Cajal bodies during splicing
CC       (PubMed:34023904). Plays a role in regulating MAGI2-mediated
CC       endocytosis (PubMed:24608321). Anchoring/scaffolding protein that is a
CC       part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A
CC       that mediates mechanotransduction in cochlear hair cells. Required for
CC       normal development and maintenance of cochlear hair cell bundles.
CC       Required for normal hearing. {ECO:0000269|PubMed:21709241,
CC       ECO:0000269|PubMed:24608321, ECO:0000269|PubMed:34023904}.
CC   -!- SUBUNIT: Part of a complex composed of USH1C, USH1G and MYO7A
CC       (PubMed:21709241, PubMed:21311020). Interacts with USH1C (via the first
CC       PDZ domain) (PubMed:20142502, PubMed:12588794). Interacts with PDZD7
CC       (PubMed:19028668). Interacts with CDH23 and PCDH15; these interactions
CC       may recruit USH1G to the plasma membrane (By similarity). Interacts
CC       with intraflagellar transport proteins IFT20, IFT52 and IFT57
CC       (PubMed:31637240). Interacts with splicing factors SF3B1, PRPF6, PRPF31
CC       and SON (PubMed:34023904). Interacts with the U4/U6.U5 tri-small
CC       nuclear ribonucleoprotein (tri-snRNP) complex in the presence of pre-
CC       mRNAs (PubMed:34023904). Interacts (via SAM domain) with MAGI2 (via PDZ
CC       6 domain); the interaction is triggered by phosphorylation of USH1G by
CC       CK2 and negatively regulates MAGI2-mediated endocytosis
CC       (PubMed:24608321). {ECO:0000250|UniProtKB:Q80T11,
CC       ECO:0000269|PubMed:12588794, ECO:0000269|PubMed:19028668,
CC       ECO:0000269|PubMed:20142502, ECO:0000269|PubMed:21311020,
CC       ECO:0000269|PubMed:21709241, ECO:0000269|PubMed:24608321,
CC       ECO:0000269|PubMed:31637240, ECO:0000269|PubMed:34023904}.
CC   -!- INTERACTION:
CC       Q495M9; X5D778: ANKRD11; NbExp=3; IntAct=EBI-8601749, EBI-17183751;
CC       Q495M9; Q13895: BYSL; NbExp=3; IntAct=EBI-8601749, EBI-358049;
CC       Q495M9; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-8601749, EBI-8643161;
CC       Q495M9; Q9H257-2: CARD9; NbExp=3; IntAct=EBI-8601749, EBI-11530605;
CC       Q495M9; Q9HC52: CBX8; NbExp=3; IntAct=EBI-8601749, EBI-712912;
CC       Q495M9; Q9UER7: DAXX; NbExp=3; IntAct=EBI-8601749, EBI-77321;
CC       Q495M9; P26196: DDX6; NbExp=3; IntAct=EBI-8601749, EBI-351257;
CC       Q495M9; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-8601749, EBI-744099;
CC       Q495M9; Q96MY7: FAM161B; NbExp=4; IntAct=EBI-8601749, EBI-7225287;
CC       Q495M9; P22607: FGFR3; NbExp=3; IntAct=EBI-8601749, EBI-348399;
CC       Q495M9; P55040: GEM; NbExp=3; IntAct=EBI-8601749, EBI-744104;
CC       Q495M9; P09067: HOXB5; NbExp=3; IntAct=EBI-8601749, EBI-3893317;
CC       Q495M9; P01112: HRAS; NbExp=3; IntAct=EBI-8601749, EBI-350145;
CC       Q495M9; O43464: HTRA2; NbExp=3; IntAct=EBI-8601749, EBI-517086;
CC       Q495M9; P42858: HTT; NbExp=3; IntAct=EBI-8601749, EBI-466029;
CC       Q495M9; Q9C086: INO80B; NbExp=3; IntAct=EBI-8601749, EBI-715611;
CC       Q495M9; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-8601749, EBI-14069005;
CC       Q495M9; P25791-3: LMO2; NbExp=3; IntAct=EBI-8601749, EBI-11959475;
CC       Q495M9; I6L9F6: NEFL; NbExp=3; IntAct=EBI-8601749, EBI-10178578;
CC       Q495M9; P54646: PRKAA2; NbExp=3; IntAct=EBI-8601749, EBI-1383852;
CC       Q495M9; Q8WWY3: PRPF31; NbExp=3; IntAct=EBI-8601749, EBI-1567797;
CC       Q495M9; P41219: PRPH; NbExp=3; IntAct=EBI-8601749, EBI-752074;
CC       Q495M9; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-8601749, EBI-748391;
CC       Q495M9; Q8N8B7-2: TCEANC; NbExp=3; IntAct=EBI-8601749, EBI-11955057;
CC       Q495M9; Q9Y6N9: USH1C; NbExp=13; IntAct=EBI-8601749, EBI-954308;
CC       Q495M9; Q495M9: USH1G; NbExp=2; IntAct=EBI-8601749, EBI-8601749;
CC       Q495M9; Q9Y649; NbExp=3; IntAct=EBI-8601749, EBI-25900580;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasm, cytoskeleton. Cell
CC       membrane {ECO:0000250|UniProtKB:Q80T11}; Peripheral membrane protein
CC       {ECO:0000305}. Cell projection, cilium {ECO:0000250|UniProtKB:Q80T11}.
CC       Nucleus speckle {ECO:0000269|PubMed:34023904}. Nucleus, Cajal body
CC       {ECO:0000269|PubMed:34023904}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250|UniProtKB:Q80T11}.
CC       Photoreceptor inner segment {ECO:0000250|UniProtKB:Q80T11}.
CC       Note=Detected at the tip of cochlear hair cell stereocilia. Recruited
CC       to the cell membrane via interaction with CDH23 or PCDH15 (By
CC       similarity). In photoreceptor cilia, detected predominantly at the
CC       cilium base (By similarity). Expressed in the pericentriolar region of
CC       the centrosome (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q80T11}.
CC   -!- TISSUE SPECIFICITY: Expressed in vestibule of the inner ear, eye and
CC       small intestine. {ECO:0000269|PubMed:12588794}.
CC   -!- DISEASE: Usher syndrome 1G (USH1G) [MIM:606943]: USH is a genetically
CC       heterogeneous condition characterized by the association of retinitis
CC       pigmentosa with sensorineural deafness. Age at onset and differences in
CC       auditory and vestibular function distinguish Usher syndrome type 1
CC       (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3).
CC       USH1 is characterized by profound congenital sensorineural deafness,
CC       absent vestibular function and prepubertal onset of progressive
CC       retinitis pigmentosa leading to blindness.
CC       {ECO:0000269|PubMed:12588794, ECO:0000269|PubMed:16283141,
CC       ECO:0000269|PubMed:20142502, ECO:0000269|PubMed:31637240}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Note=The first cases with non-syndromic sensorineural hearing
CC       loss based on mutations in USH1G. The hearing loss has an onset during
CC       early childhood, is progressive, and has a downsloping audiogram
CC       configuration. Ophthalmic and vestibular abnormalities are absent.
CC       {ECO:0000269|PubMed:25255398}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK091243; BAC03619.1; -; mRNA.
DR   EMBL; BC101096; AAI01097.1; -; mRNA.
DR   EMBL; BC101097; AAI01098.1; -; mRNA.
DR   EMBL; BC101098; AAI01099.1; -; mRNA.
DR   EMBL; BC101099; AAI01100.1; -; mRNA.
DR   CCDS; CCDS32725.1; -.
DR   RefSeq; NP_001269418.1; NM_001282489.2.
DR   RefSeq; NP_775748.2; NM_173477.4.
DR   PDB; 2L7T; NMR; -; A=370-380.
DR   PDB; 3K1R; X-ray; 2.30 A; B=388-461.
DR   PDB; 3PVL; X-ray; 2.80 A; B=295-390.
DR   PDBsum; 2L7T; -.
DR   PDBsum; 3K1R; -.
DR   PDBsum; 3PVL; -.
DR   AlphaFoldDB; Q495M9; -.
DR   SMR; Q495M9; -.
DR   BioGRID; 125876; 24.
DR   CORUM; Q495M9; -.
DR   DIP; DIP-41617N; -.
DR   ELM; Q495M9; -.
DR   IntAct; Q495M9; 28.
DR   MINT; Q495M9; -.
DR   STRING; 9606.ENSP00000480279; -.
DR   iPTMnet; Q495M9; -.
DR   PhosphoSitePlus; Q495M9; -.
DR   BioMuta; USH1G; -.
DR   DMDM; 81175048; -.
DR   MassIVE; Q495M9; -.
DR   PaxDb; Q495M9; -.
DR   PeptideAtlas; Q495M9; -.
DR   ProteomicsDB; 61966; -.
DR   Antibodypedia; 19482; 55 antibodies from 18 providers.
DR   DNASU; 124590; -.
DR   Ensembl; ENST00000614341.5; ENSP00000480279.1; ENSG00000182040.9.
DR   GeneID; 124590; -.
DR   KEGG; hsa:124590; -.
DR   MANE-Select; ENST00000614341.5; ENSP00000480279.1; NM_173477.5; NP_775748.2.
DR   UCSC; uc032fra.2; human.
DR   AGR; HGNC:16356; -.
DR   CTD; 124590; -.
DR   DisGeNET; 124590; -.
DR   GeneCards; USH1G; -.
DR   GeneReviews; USH1G; -.
DR   HGNC; HGNC:16356; USH1G.
DR   HPA; ENSG00000182040; Tissue enhanced (esophagus, skin).
DR   MalaCards; USH1G; -.
DR   MIM; 276900; phenotype.
DR   MIM; 606943; phenotype.
DR   MIM; 607696; gene.
DR   neXtProt; NX_Q495M9; -.
DR   OpenTargets; ENSG00000182040; -.
DR   Orphanet; 231169; Usher syndrome type 1.
DR   PharmGKB; PA38126; -.
DR   VEuPathDB; HostDB:ENSG00000182040; -.
DR   eggNOG; KOG0504; Eukaryota.
DR   GeneTree; ENSGT00390000017548; -.
DR   HOGENOM; CLU_028071_0_0_1; -.
DR   InParanoid; Q495M9; -.
DR   OMA; VMYVGTF; -.
DR   OrthoDB; 5395431at2759; -.
DR   PhylomeDB; Q495M9; -.
DR   TreeFam; TF324946; -.
DR   PathwayCommons; Q495M9; -.
DR   Reactome; R-HSA-9662360; Sensory processing of sound by inner hair cells of the cochlea.
DR   Reactome; R-HSA-9662361; Sensory processing of sound by outer hair cells of the cochlea.
DR   SignaLink; Q495M9; -.
DR   SIGNOR; Q495M9; -.
DR   BioGRID-ORCS; 124590; 101 hits in 1143 CRISPR screens.
DR   EvolutionaryTrace; Q495M9; -.
DR   GeneWiki; USH1G; -.
DR   GenomeRNAi; 124590; -.
DR   Pharos; Q495M9; Tbio.
DR   PRO; PR:Q495M9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q495M9; protein.
DR   Bgee; ENSG00000182040; Expressed in lower esophagus mucosa and 54 other tissues.
DR   ExpressionAtlas; Q495M9; baseline and differential.
DR   Genevisible; Q495M9; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; ISS:HGNC-UCL.
DR   GO; GO:0015030; C:Cajal body; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IEA:Ensembl.
DR   GO; GO:0097546; C:ciliary base; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0097733; C:photoreceptor cell cilium; IDA:UniProtKB.
DR   GO; GO:0032391; C:photoreceptor connecting cilium; IEA:Ensembl.
DR   GO; GO:0001917; C:photoreceptor inner segment; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030507; F:spectrin binding; IDA:MGI.
DR   GO; GO:0050957; P:equilibrioception; IMP:HGNC-UCL.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0060122; P:inner ear receptor cell stereocilium organization; IEA:Ensembl.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC-UCL.
DR   GO; GO:2000369; P:regulation of clathrin-dependent endocytosis; IMP:UniProtKB.
DR   GO; GO:0050953; P:sensory perception of light stimulus; IMP:HGNC-UCL.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:HGNC-UCL.
DR   CDD; cd21803; CEN_USH1G; 1.
DR   CDD; cd09586; SAM_USH1G; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR037602; USH1G_SAM.
DR   PANTHER; PTHR24161; ANK_REP_REGION DOMAIN-CONTAINING PROTEIN-RELATED; 1.
DR   PANTHER; PTHR24161:SF24; USHER SYNDROME TYPE-1G PROTEIN; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   SMART; SM00248; ANK; 3.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Cell membrane; Cell projection; Cytoplasm;
KW   Cytoskeleton; Deafness; Disease variant; Hearing; Membrane; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Retinitis pigmentosa;
KW   Usher syndrome.
FT   CHAIN           1..461
FT                   /note="pre-mRNA splicing regulator USH1G"
FT                   /id="PRO_0000067077"
FT   REPEAT          31..60
FT                   /note="ANK 1"
FT   REPEAT          64..93
FT                   /note="ANK 2"
FT   REPEAT          97..126
FT                   /note="ANK 3"
FT   DOMAIN          385..447
FT                   /note="SAM"
FT   REGION          208..243
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          332..368
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        221..239
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        349..366
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         422
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:24608321"
FT   VARIANT         48
FT                   /note="L -> P (in USH1G; reduced interaction with IFT52 and
FT                   IFT57; dbSNP:rs104894651)"
FT                   /evidence="ECO:0000269|PubMed:12588794,
FT                   ECO:0000269|PubMed:31637240"
FT                   /id="VAR_023739"
FT   VARIANT         104
FT                   /note="M -> V (probable disease-associated variant found in
FT                   patients with non-syndromic sensorineural hearing loss;
FT                   reduced interaction with IFT52 and IFT57; failure to rescue
FT                   the USH1C splicing defect seen in USH1G-depleted cells;
FT                   dbSNP:rs149529031)"
FT                   /evidence="ECO:0000269|PubMed:25255398,
FT                   ECO:0000269|PubMed:31637240"
FT                   /id="VAR_072369"
FT   VARIANT         458
FT                   /note="D -> V (in USH1G; atypical form with mild retinitis
FT                   pigmentosa and normal vestibular function; also found in
FT                   patients with autosomal recessive non-syndromic deafness;
FT                   strongly reduced affinity for USH1C; dbSNP:rs397517925)"
FT                   /evidence="ECO:0000269|PubMed:16283141,
FT                   ECO:0000269|PubMed:20142502"
FT                   /id="VAR_060468"
FT   MUTAGEN         307
FT                   /note="F->E: Reduced affinity for MYO7A."
FT                   /evidence="ECO:0000269|PubMed:21311020"
FT   MUTAGEN         317
FT                   /note="F->E: Reduced affinity for MYO7A."
FT                   /evidence="ECO:0000269|PubMed:21311020"
FT   MUTAGEN         374
FT                   /note="W->Q: Strongly reduced affinity for MYO7A."
FT                   /evidence="ECO:0000269|PubMed:21311020"
FT   MUTAGEN         422
FT                   /note="S->A: Abolishes interaction with MAGI2."
FT                   /evidence="ECO:0000269|PubMed:24608321"
FT   MUTAGEN         422
FT                   /note="S->E: Phosphomimetic mutant; does not affect
FT                   interaction with MAGI2."
FT                   /evidence="ECO:0000269|PubMed:24608321"
FT   CONFLICT        300
FT                   /note="D -> N (in Ref. 1; BAC03619)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        402
FT                   /note="E -> G (in Ref. 1; BAC03619)"
FT                   /evidence="ECO:0000305"
FT   STRAND          307..309
FT                   /evidence="ECO:0007829|PDB:3PVL"
FT   TURN            310..312
FT                   /evidence="ECO:0007829|PDB:3PVL"
FT   STRAND          313..315
FT                   /evidence="ECO:0007829|PDB:3PVL"
FT   STRAND          375..377
FT                   /evidence="ECO:0007829|PDB:2L7T"
FT   HELIX           391..397
FT                   /evidence="ECO:0007829|PDB:3K1R"
FT   TURN            398..400
FT                   /evidence="ECO:0007829|PDB:3K1R"
FT   HELIX           402..404
FT                   /evidence="ECO:0007829|PDB:3K1R"
FT   HELIX           405..410
FT                   /evidence="ECO:0007829|PDB:3K1R"
FT   HELIX           415..418
FT                   /evidence="ECO:0007829|PDB:3K1R"
FT   HELIX           423..428
FT                   /evidence="ECO:0007829|PDB:3K1R"
FT   HELIX           433..451
FT                   /evidence="ECO:0007829|PDB:3K1R"
FT   STRAND          459..461
FT                   /evidence="ECO:0007829|PDB:3K1R"
SQ   SEQUENCE   461 AA;  51489 MW;  B0ABB9F5711A5095 CRC64;
     MNDQYHRAAR DGYLELLKEA TRKELNAPDE DGMTPTLWAA YHGNLESLRL IVSRGGDPDK
     CDIWGNTPLH LAASNGHLHC LSFLVSFGAN IWCLDNDYHT PLDMAAMKGH MECVRYLDSI
     AAKQSSLNPK LVGKLKDKAF REAERRIREC AKLQRRHHER MERRYRRELA ERSDTLSFSS
     LTSSTLSRRL QHLALGSHLP YSQATLHGTA RGKTKMQKKL ERRKQGGEGT FKVSEDGRKS
     ARSLSGLQLG SDVMFVRQGT YANPKEWGRA PLRDMFLSDE DSVSRATLAA EPAHSEVSTD
     SGHDSLFTRP GLGTMVFRRN YLSSGLHGLG REDGGLDGVG APRGRLQSSP SLDDDSLGSA
     NSLQDRSCGE ELPWDELDLG LDEDLEPETS PLETFLASLH MEDFAALLRQ EKIDLEALML
     CSDLDLRSIS VPLGPRKKIL GAVRRRRQAM ERPPALEDTE L
//
